| Element List | Explanation |
|---|---|
| Introduction | The Board of Directors of the Middle East Healthcare Company (Saudi German Health) is pleased to announce the results of the Ordinary General Assembly meeting (First Meeting) |
| City and Location of the General Assembly's Meeting | The Ordinary General Assembly Meeting was held in person at the Company's office located on the 24th floor of King Road Tower, Jeddah, and remotely through modern technology using the Tadawulaty platform. |
| Date of the General Assembly's Meeting | 2026-07-07 Corresponding to 1448-01-22 |
| Time of the General Assembly’s Meeting | 18:30 |
| Percentage of Attending Shareholders | 70.19% |
| Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees | The meeting was attended by the Board Member Dr. Ghazi Saleh Hasanain. |
| Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf | The following Committee members attended the meeting: Dr. Ghazi Saleh Hasanain – Member of the Audit Committee and Member of the Nomination and Remuneration Committee. Absent: Mr. Karim Mostafa Abdelaal – Member of the Nomination and Remuneration Committee. |
| Voting Results on the Items of the General Assembly's Meeting Agenda's | Attached |
| Additional Information | In the event of an inquiry, we hope to contact the Shareholders Relations Department by phone number 0122606000, ext. 3129 or 3128, or by e-mail: President5@sghgroup.net |
| Attached Documents | Attached Documents |
Middle East Healthcare Company (Saudi German Health) Announces the Results of the Ordinary General Assembly Meeting (First Meeting)
AI Summary
- Approved a cash dividend distribution of SAR 46.02 million (SAR 0.50 per share) for the 2025 fiscal year, with payment to eligible shareholders scheduled to begin on July 23, 2026.
- Elected a new Board of Directors for a four-year term commencing July 8, 2026, and ending July 7, 2030, while approving SAR 1.36 million in Board remuneration for the 2025 fiscal year.
- Appointed Dr. Mohamed Al-Amri & Co. as the external auditor to audit the financial statements for the 2026 fiscal year and the first quarter of 2027 for a total fee of SAR 980,000.
- Ratified the company’s financial statements and the external auditor’s report for the fiscal year ended December 31, 2025, and discharged the Board members from their responsibilities for the same period.
Attachments
